{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:24:54Z","timestamp":1794378294767,"version":"4.9.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["62993"],"award-info":[{"award-number":["62993"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["1338"],"award-info":[{"award-number":["1338"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.meegid.2023.105449","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:33:20Z","timestamp":1684758800000},"page":"105449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reverse vaccinology approaches to introduce promising immunogenic and drug targets against antibiotic-resistant Neisseria gonorrhoeae: Thinking outside the box in current prevention and treatment"],"prefix":"10.1016","volume":"112","author":[{"given":"Narjes","family":"Noori Goodarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Ajdary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Saeed","family":"Yekaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Fereshteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Pourmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Badmasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2023.105449_bb0005","series-title":"Development of MtrE, the Outer Membrane Channel of the MtrCDE and FarAB, MtrE Active Efflux Pump Systems, as a Gonorrhea Vaccine","author":"Amanda DeRocco","year":"2014"},{"key":"10.1016\/j.meegid.2023.105449_bb0010","doi-asserted-by":"crossref","first-page":"W344","DOI":"10.1093\/nar\/gkw408","article-title":"ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules","volume":"44","author":"Ashkenazy","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0015","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3389\/fimmu.2018.02793","article-title":"Proteomics, bioinformatics and structure-function antigen mining for gonorrhea vaccines","volume":"9","author":"Baarda","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0020","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3389\/fmicb.2018.02915","article-title":"Lipid-modified Azurin of Neisseria gonorrhoeae is not surface exposed and does not interact with the nitrite reductase AniA","volume":"9","author":"Baarda","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2023.105449_bb0025","first-page":"6","article-title":"Comprehensive bioinformatic assessments of the variability of Neisseria gonorrhoeae vaccine candidates","author":"Baarda","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.meegid.2023.105449_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00977-20","article-title":"Comprehensive bioinformatic assessments of the variability of Neisseria gonorrhoeae vaccine candidates","volume":"6","author":"Baarda","year":"2021","journal-title":"Msphere"},{"key":"10.1016\/j.meegid.2023.105449_bb0035","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/JB.00171-13","article-title":"Constitutively Opa-expressing and Opa-deficient Neisseria gonorrhoeae strains differentially stimulate and survive exposure to human neutrophils","volume":"195","author":"Ball","year":"2013","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.meegid.2023.105449_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6026\/97320630005077","article-title":"A novel strategy of epitope design in Neisseria gonorrhoeae","volume":"5","author":"Barh","year":"2010","journal-title":"Bioinformation"},{"key":"10.1016\/j.meegid.2023.105449_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biologicals.2017.08.004","article-title":"Towards a peptide-based vaccine against Shigella sonnei: a subtractive reverse vaccinology based approach","volume":"50","author":"Baseer","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.meegid.2023.105449_bb0050","series-title":"Psi-Blast Tutorial, Comparative Genomics","first-page":"177","author":"Bhagwat","year":"2007"},{"key":"10.1016\/j.meegid.2023.105449_bb0055","article-title":"Brief overview of approaches and challenges in new antibiotic development: a focus on drug repurposing. Frontiers in cellular and infection","volume":"11","author":"Boyd","year":"2021","journal-title":"Microbiology"},{"key":"10.1016\/j.meegid.2023.105449_bb0060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2105-8-361","article-title":"Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines","volume":"8","author":"Bui","year":"2007","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.meegid.2023.105449_bb0065","series-title":"Antibiotic Resistance Threats in the United States, 2019","author":"CDC","year":"2019"},{"key":"10.1016\/j.meegid.2023.105449_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep24373","article-title":"BPGA-an ultra-fast pan-genome analysis pipeline","volume":"6","author":"Chaudhari","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2023.105449_bb0075","doi-asserted-by":"crossref","first-page":"W72","DOI":"10.1093\/nar\/gki396","article-title":"SCRATCH: a protein structure and structural feature prediction server","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008108","article-title":"Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops","volume":"4","author":"Cole","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2023.105449_bb0085","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s treatment guidelines for gonococcal infection, 2020","volume":"69","author":"Cyr","year":"2020","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.meegid.2023.105449_bb0090","series-title":"Human Vaccines","first-page":"65","article-title":"Chapter 3 - reverse vaccinology: Exploiting genomes for vaccine design","author":"Del Tordello","year":"2017"},{"key":"10.1016\/j.meegid.2023.105449_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"key":"10.1016\/j.meegid.2023.105449_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02700","article-title":"Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract","volume":"9","author":"Domenech","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.meegid.2023.105449_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005","journal-title":"Proteom. Protoc. Handbook"},{"key":"10.1016\/j.meegid.2023.105449_bb0115","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/AAC.00038-14","article-title":"Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae","volume":"58","author":"Golparian","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2023.105449_bb0120","article-title":"Subtractive genomic approach toward introduction of novel immunogenic targets against Clostridioides difficile: thinking out of the box","volume":"162","author":"Goodarzi","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.meegid.2023.105449_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12967-016-0928-3","article-title":"ProInflam: a webserver for the prediction of proinflammatory antigenicity of peptides and proteins","volume":"14","author":"Gupta","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.meegid.2023.105449_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.729513","article-title":"Structural biology in the clouds: the WeNMR-EOSC ecosystem","volume":"8","author":"Honorato","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.meegid.2023.105449_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/OLQ.0000000000000971","article-title":"Efficacy and safety of single-dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, noninferiority, phase 3, multicenter, randomized study","volume":"46","author":"Hook","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.meegid.2023.105449_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtbi.2016.09.004","article-title":"In-silico hierarchical approach for the identification of potential universal vaccine candidates (PUVCs) from Neisseria gonorrhoeae","volume":"410","author":"Jain","year":"2016","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.meegid.2023.105449_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/apm.12777","article-title":"In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolates","volume":"126","author":"J\u00f6nsson","year":"2018","journal-title":"Apmis"},{"key":"10.1016\/j.meegid.2023.105449_bb0150","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/biomedicines11030765","article-title":"Recent advances in monoclonal antibody-based approaches in the Management of Bacterial Sepsis","volume":"11","author":"Kharga","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.meegid.2023.105449_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1071\/SH19061","article-title":"Epidemiology of gonorrhoea: a global perspective","volume":"16","author":"Kirkcaldy","year":"2019","journal-title":"Sex. Health"},{"key":"10.1016\/j.meegid.2023.105449_bb0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/sextrans-2016-052953","article-title":"Estimating prevalence trends in adult gonorrhoea and syphilis in low-and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016","volume":"93","author":"Korenromp","year":"2017","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.meegid.2023.105449_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-00675-y","article-title":"Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand","volume":"11","author":"Kueakulpattana","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2023.105449_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.meegid.2023.105449_bb0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1071\/SH19034","article-title":"New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance","volume":"16","author":"Lewis","year":"2019","journal-title":"Sex. Health"},{"key":"10.1016\/j.meegid.2023.105449_bb0185","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00658-18","article-title":"Role of gonococcal Neisserial surface protein a (NspA) in serum resistance and comparison of its factor H binding properties with those of its meningococcal counterpart","volume":"87","author":"Lewis","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2023.105449_bb0190","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/CVI.05245-11","article-title":"Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice","volume":"18","author":"Li","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/mi.2013.36","article-title":"Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells","volume":"7","author":"Liu","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0200","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3389\/fimmu.2018.03187","article-title":"Human immune responses and the natural history of Neisseria gonorrhoeae infection","volume":"9","author":"Lovett","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0205","doi-asserted-by":"crossref","first-page":"D677","DOI":"10.1093\/nar\/gkaa917","article-title":"DEG 15, an update of the database of essential genes that includes built-in analysis tools","volume":"49","author":"Luo","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fchem.2020.00343","article-title":"Structure-based virtual screening: from classical to artificial intelligence","volume":"8","author":"Maia","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.meegid.2023.105449_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01668-19","article-title":"Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine","volume":"10","author":"Marjuki","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.meegid.2023.105449_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14745\/ccdr.v45i23a01","article-title":"Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012-2016","volume":"45","author":"Martin","year":"2019","journal-title":"Can. Commun. Dis. Rep."},{"key":"10.1016\/j.meegid.2023.105449_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.881392","article-title":"Recent Progress towards a gonococcal vaccine","volume":"12","author":"Maurakis","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.meegid.2023.105449_bb0230","doi-asserted-by":"crossref","first-page":"dlab033","DOI":"10.1093\/jacamr\/dlab033","article-title":"Exploring the implications for coincidental treatment of Mycoplasma genitalium infection in Neisseria gonorrhoeae-positive patients","volume":"3","author":"Mhango","year":"2021","journal-title":"JAC-Antimicrob. Resist."},{"key":"10.1016\/j.meegid.2023.105449_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-0716-1892-9_4","article-title":"An update on \u201creverse vaccinology\u201d: the pathway from genomes and epitope predictions to tailored, recombinant vaccines","volume":"2412","author":"Michalik","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.meegid.2023.105449_bb0240","doi-asserted-by":"crossref","first-page":"W182","DOI":"10.1093\/nar\/gkm321","article-title":"KAAS: an automatic genome annotation and pathway reconstruction server","volume":"35","author":"Moriya","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02776","article-title":"Editorial: reverse vaccinology","volume":"10","author":"Moxon","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0250","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2023.105449_bb0255","series-title":"Results of the SOLITAIRE-U Phase 3 Trial: Solithromycin Vs. Ceftriaxone+ Azithromycin for Treatment of Uncomplicated Urogenital Gonorrhea","author":"Oldach","year":"2017"},{"key":"10.1016\/j.meegid.2023.105449_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.12","article-title":"TepiTool: a pipeline for computational prediction of T cell epitope candidates","volume":"114","author":"Paul","year":"2016","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0265","series-title":"Effectiveness of a Group B OMV Meningococcal Vaccine on Gonorrhoea in New Zealand\u2013A Case Control Study","author":"Petousis-Harris","year":"2017"},{"key":"10.1016\/j.meegid.2023.105449_bb0270","doi-asserted-by":"crossref","first-page":"2200455","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455","article-title":"Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022","volume":"27","author":"Pleininger","year":"2022","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.meegid.2023.105449_bb0275","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.meegid.2023.105449_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2023.105449_bb0285","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.1003623","article-title":"Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis lip\/H.8 and Laz lipoproteins","volume":"186","author":"Ray","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2023.105449_bb0290","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.meegid.2023.105449_bb0295","series-title":"LB1. 5 the Efficacy and Safety of Gentamicin for the Treatment of Genital, Pharyngeal and Rectal Gonorrhoea: A Randomised Controlled Trial","author":"Ross","year":"2017"},{"key":"10.1016\/j.meegid.2023.105449_bb0300","first-page":"1375","article-title":"Immunity to Neisseria gonorrhoeae","author":"Russell","year":"2020","journal-title":"Front. Media SA"},{"key":"10.1016\/j.meegid.2023.105449_bb0305","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1672-0229(06)60015-6","article-title":"VICMpred: an SVM-based method for the prediction of functional proteins of gram-negative bacteria using amino acid patterns and composition","volume":"4","author":"Saha","year":"2006","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.meegid.2023.105449_bb0310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/ISI-2007-00298","article-title":"BTXpred: prediction of bacterial toxins","volume":"7","author":"Saha","year":"2007","journal-title":"In Silico Biol."},{"key":"10.1016\/j.meegid.2023.105449_bb0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41585-021-00534-5","article-title":"Outer membrane vesicle vaccines for Neisseria gonorrhoeae","volume":"19","author":"Semchenko","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.meegid.2023.105449_bb0320","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2023.105449_bb0325","article-title":"AlgPred 2.0: an improved method for predicting allergenic proteins and mapping of IgE epitopes","volume":"22","author":"Sharma","year":"2020","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.meegid.2023.105449_bb0330","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1128\/AAC.00326-12","article-title":"In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2023.105449_bb0335","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: a retrospective observational study","volume":"2","author":"Unemo","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.meegid.2023.105449_bb0340","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0345","author":"WHO"},{"key":"10.1016\/j.meegid.2023.105449_bb0350","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0355","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2023.105449_bb0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/bacteria1020009","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae in sub-Saharan populations","volume":"1","author":"Yakobi","year":"2022","journal-title":"Bacteria"},{"key":"10.1016\/j.meegid.2023.105449_bb0365","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","article-title":"PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.meegid.2023.105449_bb0370","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","article-title":"Proteomics-driven antigen discovery for development of vaccines against gonorrhea","volume":"15","author":"Zielke","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.meegid.2023.105449_bb0375","series-title":"Antimicrobial Susceptibility Testing and Molecular Characterization of Neisseria gonorrhoeae in Tehran, Iran. International journal of STD & AIDS","author":"Zolfaghari","year":"2022"},{"key":"10.1016\/j.meegid.2023.105449_bb0380","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/antibiotics9040155","article-title":"Monoclonal antibodies as an antibacterial approach against bacterial pathogens","volume":"9","author":"Zurawski","year":"2020","journal-title":"Antibiotics"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134823000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134823000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:57:33Z","timestamp":1761577053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134823000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":76,"alternative-id":["S1567134823000473"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2023.105449","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reverse vaccinology approaches to introduce promising immunogenic and drug targets against antibiotic-resistant Neisseria gonorrhoeae: Thinking outside the box in current prevention and treatment","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2023.105449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105449"}}